ื‘ืžืกื’ืจืช ืชื”ืœื™ืš ื”ืื™ืฉื•ืจย ืฉืœ ืžืกืจื™ื ื‘ืจื™ืื•ืชื™ื™ื ื‘ืื™ืจื•ืคื”, ืคืจืกืžื” EFSA ืžืงื‘ืฅ ืจื‘ื™ืขื™ ืฉืœ ื—ื•ื•ืช ื“ืขืช ืœื’ื‘ื™ ืžืกืจื™ื ืฉืื™ื ื ืžืชื™ื™ื—ืกื™ื ืœืžื—ืœื•ืช ืื• ืœื‘ืจื™ืื•ืช ื•ื”ืชืคืชื—ื•ืช ื™ืœื“ื™ื (General function claims). ืฉื™ืขื•ืจ ื”ื“ื—ื™ื™ื” ื”ื’ื‘ื•ื”, ืฉื–ื›ื” ื›ื‘ืจ ืœื‘ื™ืงื•ืจื•ืช ื ื•ืงื‘ื•ืช ื‘ืื™ืจื•ืคื”, ื ื™ื›ืจ ื’ื ื‘ืžืงื‘ืฅ ื–ื” ืฉื”ืชื™ื™ื—ืก ืœ 442 ืžืกืจื™ื. ื‘ื™ืŸ ื”"ืžืคืกื™ื“ื™ื" ื ื™ืชืŸ ืœืžื ื•ืช ืงื‘ื•ืฆื” ืฉืœ ื—ื™ื™ื“ืงื™ื ืคืจื•ื‘ื™ื•ื˜ื™ื™ื ืฉืžืกืจื™ื ื‘ืจื™ืื•ืชื™ื™ื ื”ืงื•ืฉืจื™ื ื‘ื™ืŸ ืฆืจื™ื›ืชื ืœื‘ื™ืŸ ื”ืคื—ืชื” ืฉืœ ืžื™ืงืจื•ืื•ืจื’ื ื™ื–ืžื™ื ืคืชื•ื’ื ื™ื™ื ื‘ืžืขื™, ืื• ื”ืฉืคืขื” ืขืœ ืžืขืจื›ืช ื”ื—ื™ืกื•ืŸ, ืœื ืื•ืฉืจื•. ื’ื ื”ืงืฉืจ ื‘ื™ืŸ ื‘ื˜ื-ืงืจื•ื˜ืŸ, ืœื™ืงื•ืคืŸ ื•ืœื•ื˜ืื™ืŸ (ื›ืœ ืื—ื“ ื‘ื ืคืจื“) ืœื‘ื™ืŸ ื”ื’ื ื” ืขืœ DNA, ื—ืœื‘ื•ื ื™ื ื•ืœื™ืคื™ื“ื™ื ืžืคื ื™ ื—ื™ืžืฆื•ืŸ ืื• ื”ื’ื ื” ืžืคื ื™ ื ื–ืงื™ ืงืจื™ื ืช ืฉืžืฉ ื ื“ื—ื” ืขืœ ื™ื“ื™ EFSA. ย ื‘ EFSA ืฆื™ื™ื ื• ื›ื™ ื”ื‘ืขื™ื•ืช ื”ืขื™ืงืจื™ื•ืช ื”ื™ื• ื”ื’ื“ืจื” ืœื ืžืกืคืงืช ืฉืœ ื”ืจื›ื™ื‘ ื”ืกืคืฆื™ืคื™ ืขืœื™ื• ืžื‘ื•ืกืก ื”ืžืกืจ, ื”ื™ืขื“ืจ ื”ื•ื›ื—ื•ืช ื›ื™ ื”ืืคืงื˜ ื”ื ื˜ืขืŸ ืื›ืŸ ืžื•ืขื™ืœ ืœืฉื™ืžื•ืจ ืื• ืฉื™ืคื•ืจ ืฉืœ ืชืคืงื•ื“ื™ ื”ื’ื•ืฃ, ืื• ื”ื™ืขื“ืจ ื“ื™ื•ืง ืœื’ื‘ื™ ื”ืžืกืจ ื”ื‘ืจื™ืื•ืชื™ ื”ื ื˜ืขืŸ.